Possible effects of inhibition of IKr and IKs on field-potential waveforms in the human iPS cell-derived cardiomyocytes sheet

Journal of Pharmacological Sciences

Volumn 128, Issue 2, 2015, Pages 92-95

  Matsuo, Junko ^a,b,c   Nakamura, Yuji ^a   Izumi Nakaseko, Hiroko ^a   Ando, Kentaro ^a   Sekino, Yuko ^c   Sugiyama, Atsushi ^a  

^a TOHO UNIVERSITY   (Japan)

^b SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Field potential; IKr; iPS cell derived cardiomyocytes

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; CHROMANOL 293B; DELAYED RECTIFIER POTASSIUM CHANNEL; 6-CYANO-4-(N-ETHYLSULFONYL-N-METHYLAMINO)-3-HYDROXY-2,2-DIMETHYLCHROMANE; ANTIARRHYTHMIC AGENT; CHROMAN DERIVATIVE; PIPERIDINE DERIVATIVE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PYRIDINE DERIVATIVE; SULFONAMIDE;

AFTERDEPOLARIZATION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; ELECTRIC ACTIVITY; ELECTRIC POTENTIAL; ELECTRICAL POTENTIAL PARAMETERS; FIELD POTENTIAL DURATION; HEART DEPOLARIZATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; INTER SPIKE INTERVAL; LONG QT SYNDROME 2; RELIABILITY; REPRODUCIBILITY; T WAVE; WAVEFORM; CELL CULTURE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; EVOKED RESPONSE; METABOLISM; PHYSIOLOGY; PLURIPOTENT STEM CELL; PROCEDURES;

ANTI-ARRHYTHMIA AGENTS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHROMANS; EVOKED POTENTIALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; PYRIDINES; SULFONAMIDES;

EID: 84937515746     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1016/j.jphs.2015.05.004     Document Type: Article

References (13)

1. K.R. Chi Revolution dawning in cardiotoxicity testing Nat Rev Drug Discov 12 2013 565 567
2. T. Tanaka, S. Tohyama, M. Murata, F. Nomura, T. Kaneko, H. Chen, and et al. In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes Biochem Biophys Res Commun 385 2009 497 502
3. Y. Nakamura, J. Matsuo, N. Miyamoto, A. Ojima, K. Ando, Y. Kanda, and et al. Assessment of testing methods for drug-induced repolarization delay and arrhythmias in an iPS cell-derived cardiomyocyte sheet: multi-site validation study J Pharmacol Sci 124 2014 494 501
4. M. Uesugi, A. Ojima, T. Taniguchi, N. Miyamoto, and K. Sawada Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes J Pharmacol Toxicol Methods 69 2014 177 188
5. A. Sugiyama Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts Br J Pharmacol 154 2008 1528 1537
6. M.C. Sanguinetti, and M. Tristani-Firouzi hERG potassium channels and cardiac arrhythmia Nature 440 2006 463 469
7. Y. Mizusawa, M. Horie, and A.A. Wilde Genetic and clinical advances in congenital long QT syndrome Circ J 78 2014 2827 2833
8. sK channels by the chromanol 293B Pflugers Arch 432 1996 1094 1096
9. Kr channel blockade by E-4031 on ventricular electro-mechanical relationship in the halothane-anesthetized dogs Eur J Pharmacol 740 2014 263 270
10. J. Tamargo, R. Caballero, R. Gómez, C. Valenzuela, and E. Delpón Pharmacology of cardiac potassium channels Cardiovasc Res 62 2004 9 33
11. K. Yamazaki, T. Hihara, T. Taniguchi, N. Kohmura, T. Yoshinaga, M. Ito, and et al. A novel method of selecting human embryonic stem cell-derived cardiomyocyte clusters for assessment of potential to influence QT interval Toxicol In Vitro 26 2012 335 342
12. L.S. Fridericia Die sytolendauer in elektrokardiogramm bei normalen menshen und bei herzfranken Acta Med Scand 54 1921 17 50
13. E. Carmeliet Repolarization reserve in cardiac cells J Med Biol Eng 26 2006 97 105